Alzheimer’s Drugs Market to be Worth $9.62 Billion by 2031
The Alzheimer’s Drugs Market is projected to reach $9.62 billion by 2031, growing at a CAGR of 9.8% from 2024 to 2031. The market growth is driven by the increasing global burden of Alzheimer's disease, rising prevalence of risk factors, surge in research funding, introduction of innovative technologies, increasing number of approvals, and a growing pipeline of clinical trials and...
0 Comments 0 Shares 120 Views 0 Reviews
Sponsored